Novartis AG ADR (NVS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Novartis AG ADR

NYSE | NVS

112.26

USD

+1.49 (+1.35%)

AT CLOSE (AS OF Apr 3, 2025)

$222B

MARKET CAP

18.84

P/E Ratio

5.88

EPS

$117

52 Week High

$89

52 Week Low

LIFE SCIENCES

Sector

NVS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

NVS Technicals

Tags:

NVS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$39B
Total Revenue	$52B
Cost Of Revenue	$13B
Costof Goods And Services Sold	$13B
Operating Income	$15B
Selling General And Administrative	$13B
Research And Development	$10B
Operating Expenses	$24B
Investment Income Net	-
Net Interest Income	-$608M
Interest Income	$568M
Interest Expense	$1B
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$6.1B
Income Before Tax	$14B
Income Tax Expense	$1.7B
Interest And Debt Expense	-
Net Income From Continuing Operations	$12B
Comprehensive Income Net Of Tax	-
Ebit	$15B
Ebitda	$21B
Net Income	$12B

Revenue & Profitability

Earnings Performance

NVS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$102B
Total Current Assets	$30B
Cash And Cash Equivalents At Carrying Value	$11B
Cash And Short Term Investments	$11B
Inventory	$5.7B
Current Net Receivables	-
Total Non Current Assets	$73B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$27B
Intangible Assets Excluding Goodwill	$27B
Goodwill	$25B
Investments	-
Long Term Investments	$1.1B
Short Term Investments	$1.9B
Other Current Assets	$1.1B
Other Non Current Assets	-
Total Liabilities	$58B
Total Current Liabilities	$29B
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$8.3B
Total Non Current Liabilities	$29B
Capital Lease Obligations	$1.8B
Long Term Debt	$21B
Current Long Term Debt	$8.1B
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$31B
Other Current Liabilities	$13B
Other Non Current Liabilities	$1B
Total Shareholder Equity	$44B
Treasury Stock	-
Retained Earnings	-
Common Stock	$793M
Common Stock Shares Outstanding	$2B

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$18B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$6.1B
Capital Expenditures	$3.8B
Change In Receivables	-
Change In Inventory	-$225M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	-$12B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$7.6B
Dividend Payout Common Stock	$7.6B
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$8.3B
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$12B

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$39B
Total Revenue	$52B
Cost Of Revenue	$13B
Costof Goods And Services Sold	$13B
Operating Income	$15B
Selling General And Administrative	$13B
Research And Development	$10B
Operating Expenses	$24B
Investment Income Net	-
Net Interest Income	-$608M
Interest Income	$568M
Interest Expense	$1B
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$6.1B
Income Before Tax	$14B
Income Tax Expense	$1.7B
Interest And Debt Expense	-
Net Income From Continuing Operations	$12B
Comprehensive Income Net Of Tax	-
Ebit	$15B
Ebitda	$21B
Net Income	$12B

Dividends

Field	Value
Ex Dividend Date	2025-03-12
Declaration Date	None
Record Date	None
Payment Date	None
Amount	3.869541

NVS Profile

Novartis AG ADR Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	776,312,724
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	242,972,129
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.81	2.86%	$399.65B	13,235,689
PG	$172.39	1.71%	$399.61B	9,393,270
ABBV	$201.64	-1.73%	$364.89B	7,580,327
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$73.92	2.35%	$225.70B	7,926,952

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$744.62K	310,904
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,499,750
OMQS	$0.06	62.16%	$1.50M	59,659

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
ICCT	$2.07	-56.14%	$9.78M	12,637,345